Mesoblast Stock Quote MSB - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.09

Bid

2.08

Ask

2.10

Volume

9,036,662

2.05 Day's Range 2.21

0.295 52 Week Range 3.37

Market Cap

1.539B

Previous Close

2.21

Open

2.15

Last Trade

12735

2.09

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

8,712,443

Shares Outstanding

736,578,315

Dividend Yield

PE Ratio

-17.50

Earnings Per Share (EPS)

-0.12

Revenue

9.25M

Net Profit

-87.96M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.mesoblast.com

Headquarters

Melbourne, Victoria, Aus

Founded

Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker MSB. The last closing price for Mesoblast was AUD2.21. Over the last year, Mesoblast shares have traded in a share price range of AUD 0.295 to AUD 3.37.

Mesoblast currently has 736,578,315 shares outstanding. The market capitalization of Mesoblast is AUD1.63 billion. Mesoblast has a price to earnings ratio (PE ratio) of -17.50.

Mesoblast Gets FDA's Special Pediatric Designation for Revascor Heart Treatment

By Dean Seal Mesoblast said regulators have granted their rare pediatric disease designation to its cell therapy Revascor for children with...

Mesoblast ADSs Plunge Premarket on Latest FDA Rejection

By Colin Kellaher American depositary shares of Mesoblast plummeted more than 65% in premarket trading Friday after the biopharmaceutical...

FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing

Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD...

Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission

By Colin Kellaher American depositary shares of Mesoblast Ltd. jumped more than 15% in early trading Wednesday after the biopharmaceutical company...

Mesoblast Shares Rise 11% After Resubmitting Biologics License Application

By Chris Wack Mesoblast Ltd. shares were up 11% to $3.67 Wednesday after the company said it resubmitted a biologics license application to the...

Mesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-L

By Chris Wack Mesoblast Ltd. shares were up 10% to $2.80 after the company said it submitted substantial new information to the U.S. Food and Drug...

Mesoblast to Hold Type C Meeting With FDA for Back Pain Treatment

By Chris Wack Mesoblast Ltd. said it has filed a request and expects to hold a Type C meeting with the U.S. Food & Drug Administration during...

Mesoblast Up 25% After Hours on Collaboration With Novartis

By Josh Beckerman Mesoblast Ltd. American depositary receipts surged 25% to $14.70 after hours as the company entered an exclusive worldwide...

Mesoblast Named Global Technology Leader in Cell Therapy Industry

Mesoblast Limited has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry. Mesoblast is...

Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment of Acute Graft Versus Host Disease

MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.6	-22.3048327138	2.69	2.75	2.05	12870175	2.42179955	DE
4	-0.87	-29.3918918919	2.96	3.13	2.05	6399023	2.61725511	DE
12	0.49	30.625	1.6	3.37	1.545	8712443	2.71397974	DE
26	1.11	113.265306122	0.98	3.37	0.915	6400852	2.21037476	DE
52	1.795	608.474576271	0.295	3.37	0.295	8038268	1.41146894	DE
156	1.06	102.912621359	1.03	3.37	0.255	4374235	1.12467567	DE
260	-0.08	-3.6866359447	2.17	5.7	0.255	4711590	1.9807308	DE

MSB - Frequently Asked Questions (FAQ)

What is the current Mesoblast share price?

The current share price of Mesoblast is AUD 2.09

How many Mesoblast shares are in issue?

Mesoblast has 736,578,315 shares in issue

What is the market cap of Mesoblast?

The market capitalisation of Mesoblast is AUD 1.63B

What is the 1 year trading range for Mesoblast share price?

Mesoblast has traded in the range of AUD 0.295 to AUD 3.37 during the past year

What is the PE ratio of Mesoblast?

The price to earnings ratio of Mesoblast is -17.5

What is the cash to sales ratio of Mesoblast?

The cash to sales ratio of Mesoblast is 165.87

What is the reporting currency for Mesoblast?

Mesoblast reports financial results in USD

What is the latest annual turnover for Mesoblast?

The latest annual turnover of Mesoblast is USD 9.25M

What is the latest annual profit for Mesoblast?

The latest annual profit of Mesoblast is USD -87.96M

What is the registered address of Mesoblast?

The registered address for Mesoblast is LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, 3000

What is the Mesoblast website address?

The website address for Mesoblast is www.mesoblast.com

Which industry sector does Mesoblast operate in?

Mesoblast operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JAYJayride Group Limited	AUD 0.003 (50.00%)	200k
EGNEngenco Ltd	AUD 0.29 (38.10%)	1.47M
NUCNuchev Limited	AUD 0.20 (37.93%)	138.99k
IRXInhaleRx Ltd	AUD 0.037 (37.04%)	438.57k
SPAOSpacetalk Ltd	AUD 0.05 (35.14%)	55k
M2MOMT Malcolm Mines NL	AUD 0.003 (-50.00%)	141k
ERGEneco Refresh Limited	AUD 0.009 (-35.71%)	2.16M
FFFOForbidden Foods Limited	AUD 0.002 (-33.33%)	1.5M
FAUFirst AU Limited	AUD 0.002 (-33.33%)	6.57M
HTMOHighTech Metals Ltd	AUD 0.035 (-28.57%)	62.5k
AVEOAAvecho Biotechnology Limited	AUD 0.001 (0.00%)	83.47M
ROGRed Sky Energy Limited	AUD 0.006 (0.00%)	45.11M
SYASayona Mining Limited	AUD 0.02 (0.00%)	44.71M
VAUVault Minerals Ltd	AUD 0.4125 (-0.60%)	39.89M
TLSTelstra Corporation Limited	AUD 4.17 (-0.12%)	21.88M